EUVIMEDAvasta EUVIMED
Crossref

Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation

Pooja Budhiraja iD, Kunam S Reddy iD, Raymond L Heilman iD, Caroline C Jadlowiec iD, Hassan Khamash iD, Swetha Reddy iD, Nitin Katariya, Harini A Chakkera iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15062 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Pooja Budhiraja and 7 co-authors. Institution: Division of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA. Major MEDLINE topics: Diabetes Mellitus, Type 2, Kidney Transplantation, Pancreas Transplantation. Cited 1 times so far (Crossref); 54 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

The objective of this study was to compare the long‐term outcomes of Hispanic versus white recipients who underwent simultaneous pancreas kidney transplantation (SPKT). This single‐center study, conducted from 2003 to 2022, had a median follow‐up of 7.5 years. The study included 91 Hispanic and 202 white SPKT recipients. The mean age (44 vs. 46 years), percentage of males (67% vs. 58%), and body mass index (BMI) (25.6 vs. 25.3 kg/m 2 ) were similar between the Hispanic and white groups. The Hispanic group had more recipients with type 2 diabetes (38%) compared to the white group (5%, p < .001). The duration of dialysis was longer in Hispanics (640 vs. 473 days, p = .02), and fewer patients received preemptive transplants (10% vs. 29%, p < .01) compared to whites. Hospital length of stay, rates of BK Viremia, and acute rejection episodes within 1 year were similar between the groups. The estimated 5‐year kidney, pancreas, and patient survival rates were also similar between the groups, 94%, 81%, and 95% in Hispanics, compared to 90%, 79%, and 90% in whites. Increasing age and longer duration of dialysis were risk factors for death. Although Hispanic recipients had a longer duration on dialysis and fewer preemptive transplants, the survival rates were similar to those of white recipients. However, referring providers and many transplant centers continue to overlook pancreas transplants for appropriately selected patients with type 2 diabetes, particularly among minority populations. As a transplant community, it is crucial that we make efforts to comprehend and tackle these obstacles to transplantation.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Kidney TransplantationPancreas TransplantationHumansMaleGraft SurvivalHispanic or LatinoPancreasFemaleAdultMiddle Aged

Author keywords

Hispanicgraft survivalracesimultaneous pancreas-kidney transplantationwhites

Authors and institutions

  • Division of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA.

ORCID profiles: Pooja Budhiraja, Kunam S Reddy, Raymond L Heilman, Caroline C Jadlowiec, Hassan Khamash, Swetha Reddy, Harini A Chakkera

Cite

APA

Budhiraja, P., Reddy, K. S., Heilman, R. L., Jadlowiec, C. C., Khamash, H., Reddy, S., Katariya, N., & Chakkera, H. A. (2023). Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15062

Vancouver

Budhiraja P, Reddy KS, Heilman RL, Jadlowiec CC, Khamash H, Reddy S, et al. Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation. Clinical Transplantation. 2023. doi:10.1111/ctr.15062

BibTeX
@article{Budhiraja2023,
  author = {Budhiraja, Pooja and Reddy, Kunam S and Heilman, Raymond L and Jadlowiec, Caroline C and Khamash, Hassan and Reddy, Swetha and Katariya, Nitin and Chakkera, Harini A},
  title = {Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15062}
}
Start for free →